Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8497562 | Comparative Immunology, Microbiology and Infectious Diseases | 2016 | 6 Pages |
Abstract
The aims of this study were: the identification of proteins differentially represented in the serum proteome of dogs with leishmaniosis after treatment and the verification of one selected protein as a possible biomarker for treatment monitoring. Serum samples from five dogs with leishmaniosis, before and after treatment were pooled into two groups and analysed using 2-dimensional electrophoresis followed by mass spectrometry analysis (MS). The MS analysis allowed the identification of 8 proteins differently expressed. APO-A1 was selected and an immunoturbidimetric assay was validated for its measurement in dogs. Significantly decreased concentrations of APO-A1 in dogs with leishmaniosis and a significant increase after a good response to the treatment were observed, suggesting that APO-A1 could be a potential biomarker of treatment monitoring with the advantages of an automated measurement.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Animal Science and Zoology
Authors
Damián Escribano, Asta Tvarijonaviciute, Meric Kocaturk, Jose JoaquÃn Cerón, Luis Pardo-MarÃn, Alejandro Torrecillas, Zeki Yilmaz, Silvia MartÃnez-Subiela,